Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (647) 647
science & technology (583) 583
life sciences & biomedicine (581) 581
female (463) 463
chemotherapy (424) 424
chemotherapy-induced nausea and vomiting (422) 422
oncology (413) 413
middle aged (411) 411
nausea - chemically induced (397) 397
male (389) 389
cancer (342) 342
vomiting - chemically induced (341) 341
aged (328) 328
adult (320) 320
nausea (304) 304
antineoplastic agents - adverse effects (278) 278
antineoplastic combined chemotherapy protocols - adverse effects (248) 248
antiemetics - therapeutic use (227) 227
antineoplastic combined chemotherapy protocols - therapeutic use (218) 218
vomiting (210) 210
vomiting - prevention & control (188) 188
nausea - prevention & control (187) 187
medicine & public health (169) 169
neoplasms - drug therapy (161) 161
health care sciences & services (140) 140
nursing (134) 134
quality of life (125) 125
rehabilitation (122) 122
vomiting - drug therapy (119) 119
treatment outcome (118) 118
care and treatment (115) 115
aprepitant (114) 114
nausea - drug therapy (114) 114
palonosetron (114) 114
pharmacology & pharmacy (112) 112
pain medicine (105) 105
cisplatin - adverse effects (104) 104
analysis (101) 101
antiemetics (101) 101
rehabilitation medicine (100) 100
dexamethasone (99) 99
prevention (99) 99
cisplatin - administration & dosage (95) 95
drug administration schedule (95) 95
aged, 80 and over (94) 94
antiemetics - administration & dosage (89) 89
antineoplastic agents - therapeutic use (89) 89
complications and side effects (78) 78
patients (77) 77
prospective studies (75) 75
clinical trials (74) 74
young adult (72) 72
biological and medical sciences (71) 71
breast neoplasms - drug therapy (70) 70
risk factors (70) 70
breast cancer (68) 68
gastrointestinal agents (68) 68
health aspects (68) 68
research (68) 68
cancer therapies (67) 67
dexamethasone - therapeutic use (67) 67
medical sciences (67) 67
nursing management/nursing research (67) 67
drug therapy (64) 64
hematology (64) 64
morpholines - therapeutic use (63) 63
adolescent (62) 62
drug therapy, combination (62) 62
isoquinolines - therapeutic use (60) 60
quinuclidines - therapeutic use (60) 60
cancer patients (59) 59
leukopenia - chemically induced (58) 58
antineoplastic combined chemotherapy protocols - administration & dosage (56) 56
double-blind method (56) 56
antiemetic (55) 55
antiemetics - adverse effects (55) 55
antineoplastic agents (55) 55
chemotherapy-induced peripheral neuropathy (55) 55
survival rate (55) 55
lung neoplasms - drug therapy (54) 54
retrospective studies (54) 54
granisetron (52) 52
pharmacology. drug treatments (52) 52
side effects (51) 51
chemotherapy induced nausea and vomiting (50) 50
chemotherapy‐induced nausea and vomiting (49) 49
fluorouracil - administration & dosage (48) 48
dosage and administration (47) 47
neoplasm staging (47) 47
remission induction (46) 46
olanzapine (45) 45
serotonin antagonists - therapeutic use (45) 45
fluorouracil - adverse effects (44) 44
original (44) 44
antineoplastic agents - administration & dosage (43) 43
cisplatin (43) 43
dose-response relationship, drug (43) 43
drug dosages (43) 43
medical research (43) 43
neutropenia - chemically induced (43) 43
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (799) 799
Japanese (117) 117
Chinese (57) 57
German (8) 8
French (2) 2
Hungarian (2) 2
Russian (2) 2
Spanish (2) 2
Croatian (1) 1
Danish (1) 1
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Methodology Aspects of Nausea Measuring During Pelvic Radiotherapy: Daily Nausea Measuring Is Successful to Identify Patients Experiencing Nausea
by Enblom, Anna E and Steineck, Gunnar and Börjeson, Sussanne and Institute of Clinical Sciences, Department of Oncology and Sahlgrenska akademin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy and Institutionen för kliniska vetenskaper, Avdelningen för onkologi
Cancer nursing, ISSN 0162-220X, 03/2020, Volume 43, Issue 2, pp. 93 - 104
Nausea questionnaire | Methodology | Cancer care | Nursing theory | Patient-reported outcomes | Symptom documentation | Oncology care | Emesis | Quality of life | Oncology | Nursing | Life Sciences & Biomedicine | Science & Technology | Index Medicus | radiation-induced nausea | participation | chemotherapy-induced nausea | documentation | impact | cancer survivors | management | functional assessment | quality-of-life | Cancer and Oncology | Symptom | prevention | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists
by Bošnjak, Snežana M and Gralla, Richard J and Schwartzberg, Lee
Supportive care in cancer, ISSN 0941-4355, 5/2017, Volume 25, Issue 5, pp. 1661 - 1671
Chemotherapy-induced nausea and vomiting (CINV) | Pain Medicine | Nursing | Rehabilitation Medicine | Medicine & Public Health | Nursing Research | NK 1 receptor antagonist | Chemotherapy-induced nausea (CIN) | Oncology | Antiemetic guidelines | receptor antagonist | Health Care Sciences & Services | Rehabilitation | Life Sciences & Biomedicine | Science & Technology | Vomiting - chemically induced | Nausea - chemically induced | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Humans | Neurokinin-1 Receptor Antagonists - therapeutic use | Quality of Life - psychology | Prevention | Medical colleges | Chemotherapy | Dexamethasone | Nausea | Patient compliance | Cancer | Side effects | Antagonist drugs | Clinical outcomes | Meta-analysis | Index Medicus | Review | NK1 receptor antagonist
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Improved Prevention of Moderately Emetogenic Chemotherapy-Induced Nausea and Vomiting with Palonosetron, a Pharmacologically Novel 5-HT3 Receptor Antagonist: Results of a Phase III, Single-Dose Trial Versus Dolasetron
by Eisenberg, Peter and Figueroa-Vadillo, Jazmin and Zamora, Rosalio and Charu, Veena and Hajdenberg, Julio and Cartmell, Alan and Macciocchi, Alberto and Grunberg, Steven and 99-04 Palonosetron Study Group
Cancer, ISSN 0008-543X, 12/2003, Volume 98, Issue 11, pp. 2473 - 2482
Dolasetron | 5-HT | receptor antagonist | Antiemetic | Chemotherapy-induced nausea and vomiting | Palonosetron | Life Sciences & Biomedicine | Oncology | Science & Technology | Toxicity: digestive system | Biological and medical sciences | Medical sciences | Drug toxicity and drugs side effects treatment | Pharmacology. Drug treatments | Quinolizines - therapeutic use | Isoquinolines - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Isoquinolines - pharmacology | Quinuclidines - therapeutic use | Antiemetics - therapeutic use | Adult | Antiemetics - adverse effects | Female | Indoles - pharmacology | Quinolizines - adverse effects | Vomiting - prevention & control | Quinuclidines - adverse effects | Severity of Illness Index | Double-Blind Method | Quinuclidines - pharmacology | Treatment Outcome | Quinolizines - pharmacology | Neoplasms - drug therapy | Vomiting - chemically induced | Indoles - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Isoquinolines - therapeutic use | Indoles - therapeutic use | Aged | Infusions, Intravenous | Antiemetics - pharmacology | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Efficacy of the neurokinin‐1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin‐based chemotherapy
by Hesketh, Paul J and Schnadig, Ian D and Schwartzberg, Lee S and Modiano, Manuel R and Jordan, Karin and Arora, Sujata and Powers, Dan and Aapro, Matti
Cancer, ISSN 0008-543X, 08/2016, Volume 122, Issue 15, pp. 2418 - 2425
moderately emetogenic chemotherapy | chemotherapy‐induced nausea and vomiting | carboplatin | neurokinin‐1 receptor antagonist | rolapitant | Carboplatin | Moderately emetogenic chemotherapy | Rolapitant | Neurokinin-1 receptor antagonist | Chemotherapy-induced nausea and vomiting | Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Spiro Compounds - therapeutic use | Spiro Compounds - adverse effects | Carboplatin - adverse effects | Neoplasms - complications | Aged, 80 and over | Adult | Female | Nausea - drug therapy | Vomiting - prevention & control | Neurokinin-1 Receptor Antagonists - adverse effects | Chemoprevention | Neurokinin-1 Receptor Antagonists - therapeutic use | Risk Factors | Carboplatin - administration & dosage | Neoplasms - mortality | Treatment Outcome | Vomiting - drug therapy | Neoplasms - drug therapy | Nausea - prevention & control | Nausea - etiology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vomiting - etiology | Aged | Complications and side effects | Care and treatment | Chemotherapy | Nausea | Dosage and administration | Cancer | Index Medicus | Abridged Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients’ quality of life
by Fernández-Ortega, P and Caloto, M T and Chirveches, E and Marquilles, R and Francisco, J San and Quesada, A and Suárez, C and Zorrilla, I and Gómez, J and Zabaleta, P and Nocea, G and Llombart-Cussac, A
Supportive care in cancer, ISSN 0941-4355, 12/2012, Volume 20, Issue 12, pp. 3141 - 3148
Pain Medicine | Rehabilitation Medicine | Nursing | Medicine & Public Health | Emetogenous chemotherapy | Oncology | Nursing Management/Nursing Research | Chemotherapy-induced nausea and vomiting | Quality of life | Health Care Sciences & Services | Rehabilitation | Life Sciences & Biomedicine | Science & Technology | Lung Neoplasms - drug therapy | Prospective Studies | Nausea - chemically induced | Humans | Middle Aged | Male | Breast Neoplasms - drug therapy | Nausea - psychology | Neoplasms - drug therapy | Nausea - prevention & control | Vomiting - chemically induced | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Vomiting - psychology | Quality of Life | Adult | Female | Surveys and Questionnaires | Aged | Vomiting - prevention & control | Chemotherapy | Cancer patients | Nausea | Cancer | Side effects | Vomiting | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Duration of dexamethasone administration for the prevention of chemotherapy-induced nausea and vomiting – A systematic review and meta-analysis
by Raghunath, Ajay and Chandrasekara, Sahan D and Anthony, Shane N and Markman, Ben
Critical reviews in oncology/hematology, ISSN 1040-8428, 08/2020, Volume 152, pp. 103012 - 103012
NK1 inhibitors | Systematic review | Dexamethasone | Corticosteroids | Chemotherapy-induced nausea and vomiting | Meta-analysis | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Prevention | Medical research | Complications and side effects | Chemotherapy | Analysis | Medicine, Experimental | Nausea | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review
by Jordan, K and Jahn, F and Aapro, M
Annals of oncology, ISSN 0923-7534, 06/2015, Volume 26, Issue 6, pp. 1081 - 1090
olanzapine | guidelines | chemotherapy-induced nausea and vomiting CINV | NEPA | rolapitant | antiemetics | Antiemetics | Olanzapine | Rolapitant | Chemotherapy-induced nausea and vomiting CINV | Guidelines | Life Sciences & Biomedicine | Oncology | Science & Technology | Nausea - chemically induced | Humans | Neurokinin-1 Receptor Antagonists - therapeutic use | Drug Discovery - trends | Spiro Compounds - therapeutic use | Treatment Outcome | Nausea - prevention & control | Vomiting - chemically induced | Animals | Guideline Adherence | Quinuclidines - therapeutic use | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Serotonin Antagonists | Isoquinolines - therapeutic use | Vomiting - prevention & control | Practice Guidelines as Topic | Pyridines - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Chemotherapy‐Induced Nausea and Vomiting Prophylaxis: Practice Within the Children's Oncology Group
by Patel, Priya and Robinson, Paula D and Orsey, Andrea and Freedman, Jason L and Langevin, Anne‐Marie and Woods, Debbie and Sung, Lillian and Dupuis, L. Lee
Pediatric blood & cancer, ISSN 1545-5009, 05/2016, Volume 63, Issue 5, pp. 887 - 892
antiemetic | chemotherapy‐induced vomiting | supportive care | pediatrics | nausea | vomiting | Pediatrics | Supportive care | Nausea | Chemotherapy-induced vomiting | Vomiting | Antiemetic | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Nausea - chemically induced | Humans | Middle Aged | Antiemetics - administration & dosage | Child, Preschool | Infant | Male | Neoplasms - drug therapy | Nausea - prevention & control | Vomiting - chemically induced | Adult | Female | Surveys and Questionnaires | Child | Vomiting - prevention & control | Chemotherapy | Gastrointestinal agents | Analysis | Pharmacists | Drug therapy | Cancer | Children & youth | Index Medicus | chemotherapy-induced vomiting
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Efficacy of olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis
by Chiu, Leonard and Chow, Ronald and Popovic, Marko and Navari, Rudolph M and Shumway, Nathan M and Chiu, Nicholas and Lam, Henry and Milakovic, Milica and Pasetka, Mark and Vuong, Sherlyn and Chow, Edward and DeAngelis, Carlo
Supportive care in cancer, ISSN 0941-4355, 5/2016, Volume 24, Issue 5, pp. 2381 - 2392
Pain Medicine | Nursing | Rehabilitation Medicine | Olanzapine | Medicine & Public Health | Prophylaxis | Oncology | Efficacy | Breakthrough emesis | Nursing Management/Nursing Research | Chemotherapy-induced nausea and vomiting | Health Care Sciences & Services | Rehabilitation | Life Sciences & Biomedicine | Science & Technology | Vomiting - chemically induced | Nausea - chemically induced | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Humans | Antiemetics - administration & dosage | Benzodiazepines - administration & dosage | Female | Benzodiazepines - therapeutic use | Induction Chemotherapy - adverse effects | Chemotherapy | Nausea | Gastrointestinal agents | Analysis | Cancer | Side effects | Vomiting | Meta-analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients
by Janelsins, Michelle C and Tejani, Mohamedtaki A and Kamen, Charles and Peoples, Anita R and Mustian, Karen M and Morrow, Gary R
Expert opinion on pharmacotherapy, ISSN 1465-6566, 04/2013, Volume 14, Issue 6, pp. 757 - 766
cancer treatments | anticipatory nausea and vomiting | emesis | chemotherapy | chemotherapy-induced nausea and vomiting | nausea | vomiting | Anticipatory nausea and vomiting | Chemotherapy | Cancer treatments | Vomiting | Nausea | Emesis | Chemotherapy-induced nausea and vomiting | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Nausea - chemically induced | Humans | Antineoplastic Agents - therapeutic use | Nausea - physiopathology | Nausea - prevention & control | Vomiting - chemically induced | Clinical Trials, Phase III as Topic | Animals | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Drug Design | Quality of Life | Vomiting - physiopathology | Vomiting - prevention & control | Clinical Trials, Phase II as Topic | Practice Guidelines as Topic | Index Medicus | chemotherapy-induced | nausea and vomiting
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights